ANSTO's innovative approach to treating cancer gets funding
An international team led by ANSTO has been awarded a prestigious program grant from the Foundation for Australia-Japan Studies.
Showing 841 - 860 of 1045 results
An international team led by ANSTO has been awarded a prestigious program grant from the Foundation for Australia-Japan Studies.
Researchers use Kitaev theoretical model to explain unusual phenomenon in two-dimensional material.
The complex engineering of scientific instruments is explored in this 'behind the scenes' look at the installation of frontends for two new beamlines at the Australian Synchrotron.
Four international authorities will deliver plenary addresses virtually at the 15th International Conference on Accelerator Mass Spectrometry (AMS15) , which will be held online from 15-19 November.
Australian clean energy technology company, entX Limited is taking advantage of ANSTO’s unique capacity to generate tailored radioisotope products in the OPAL multi-purpose nuclear reactor to advance a series of innovative projects.
ANSTO’s Innovation Precinct has been highlighted in the Greater Sydney Commission’s South District Plan.
ANSTO sets out the following terms and conditions relating to users who access our facilities for the purpose of research.
Modified component of green tea promises potential neuroblastoma treatment.
Research highlights how biodistribution of a toxic substance essential to understand all exposure risks.
Lutetium-177 used for advanced prostate cancer
Wolfgang Kubicki, MdB and a small delegation visited to see the Spatz neutron instrument donated by Helmholtz Zentrum Berlin (HZB) and discuss research.
Consortium will map the 86 billion nerve cells, 100 trillion connections and neurotransmitters in the human brain.
Specifications, Instrument layout, and Instrument reference
Letter to Editor of the Sydney Morning Herald following publication of news report
Neutron scattering techniques help characterise the structure of a particle based emulsifier